Skip to main content
An official website of the United States government

siltuximab

View Patient Information
A chimeric, human-murine, monoclonal antibody targeting the pro-inflammatory cytokine interleukin 6 (IL-6), with antitumor and anti-inflammatory activities. Upon intravenous administration of siltuximab, this agent targets and binds to IL-6. This inhibits the binding of IL-6 to the IL-6 receptor (IL-6R), which results in the blockade of the IL-6/IL-6R-mediated signal transduction pathway. This inhibits cancer cell growth in tumors overexpressing IL-6.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
US brand name:Sylvant
Code name:cCLB8
CNTO-328
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search